Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov-Dec;6(6):565-70.
Epub 2015 Nov 1.

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer

Heather Cox  1 , Megan Hames  1 , Mona Benrashid  1
Affiliations
Review

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer

Heather Cox et al. J Adv Pract Oncol. 2015 Nov-Dec.
No abstract available

PubMed Disclaimer

Figures

Table 1
Table 1
ALSYMPCA Trial Inclusion and Exclusion Criteria
Table 2
Table 2
Hematologic Adverse Reactions Observed in the ALSYMPCA Trial
Table 3
Table 3
Hematologic Criteria for Radium-223
Table 4
Table 4
Patient Counseling Information
See this image and copyright information in PMC

References

    1. American Cancer Society . Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
    1. Basch Ethan, Loblaw D Andrew, Oliver Thomas K, Carducci Michael, Chen Ronald C, Frame James N, Garrels Kristina, Hotte Sebastien, Kattan Michael W, Raghavan Derek, Saad Fred, Taplin Mary-Ellen, Walker-Dilks Cindy, Williams James, Winquist Eric, Bennett Charles L, Wootton Ted, Rumble R Bryan, Dusetzina Stacie B, Virgo Katherine S. Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32:3436–3448. - PMC - PubMed
    1. Xofigo (radium-223 chloride) package insert. . Bayer HealthCare Pharmaceuticals, Inc. . 2013 Retrieved from http://hcp.xofigo-us.com/index.php.
    1. Bellmunt Joaquim. Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients. European urology. 2013;63:198–200. - PubMed
    1. Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser T C, Mihatsch M J. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Human pathology. 2000;31:578–583. - PubMed

LinkOut - more resources